Page last updated: 2024-10-17

3-hydroxybutyric acid and Basal Ganglia Cerebrovascular Disease

3-hydroxybutyric acid has been researched along with Basal Ganglia Cerebrovascular Disease in 1 studies

3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.

Basal Ganglia Cerebrovascular Disease: A pathological condition caused by impaired blood flow in the basal regions of cerebral hemispheres (BASAL GANGLIA), such as INFARCTION; HEMORRHAGE; or ISCHEMIA in vessels of this brain region including the lateral lenticulostriate arteries. Primary clinical manifestations include involuntary movements (DYSKINESIAS) and muscle weakness (HEMIPARESIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stenerson, MB1
Collura, CA1
Rose, CH1
Lteif, AN1
Carey, WA1

Other Studies

1 other study available for 3-hydroxybutyric acid and Basal Ganglia Cerebrovascular Disease

ArticleYear
Bilateral basal ganglia infarctions in a neonate born during maternal diabetic ketoacidosis.
    Pediatrics, 2011, Volume: 128, Issue:3

    Topics: 3-Hydroxybutyric Acid; Adult; Basal Ganglia Cerebrovascular Disease; Brain Infarction; Dehydration;

2011